MRVIMaravai LifeSciences Holdings, Inc.

$8.90

Is it safe?

Can MRVI take a bad year?

The deepest fall in MRVI's price history on file is −97%; it is −1.0% below its high today.

$75M

Net debt · as at Q1 2026 · debt less the cash on hand

Altman Z-score
3.13

Altman Z-score · safe zone, above 3

Cash runway
3.1 years

Cash runway · burning $13M a quarter at the current rate

Annualised volatility
81%

Annualised volatility · three times the market's own swing

Details
Total debtQ1 2026
$241M
Cash and short-term investments
$166M
Net debt
$75M
EBITDA, trailing twelve months
−$145M
Operating profit, trailing twelve months
−$168M
Debt / equity
1.14×
Annualised volatilitytwo years of daily moves
81%
Worst drawdown on file
−97%
Below its 52-week high
−1.0%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.